Brazil SUS to Start Bowel Câncer Screening at 50 in December; Age Cutoff Based on Resources, Not Risk
Brazil’s public health system starts offering bowel cancer screening tests in December, and the program’s age cutoff is already under scrutiny.
The Health Ministry set the protocol for symptom-free people aged 50 to 75, using a fecal immunochemical test every two years, UOL reported, according to Meio News.
- The SUS will offer fecal immunochemical testing (FIT) from December to asymptomatic people aged 50 to 75, starting in state capitals and cities with more than 500,000 residents.
- Colorectal cancer is rising sharply among younger Brazilians — up more than 7% a year in people under 50 — yet the public program keeps its starting age at 50 because of colonoscopy capacity limits.
- Anyone with symptoms, at any age, should not wait for the screening program: blood in the stool, persistent abdominal pain, unexplained weight loss or changes in bowel habits require medical evaluation.
A first for Brazil’s public system
The program is the first colorectal cancer screening initiative ever rolled out across Brazil’s public health network, according to reporting by Estadão. The Health Ministry and the National Cancer Institute (INCA) had faced years of pressure from medical and scientific societies to create one, especially as diagnoses climbed.
The Ministry added the FIT test to the SUS procedure table in August, a move it says extends prevention to more than 40 million Brazilians, Correio do Povo reported. Estadão, citing IBGE data, put the eligible population at 51 million people — but only 400,000 tests will be distributed immediately.
Why the screening age stays at 50
The choice of 50 is a resource calculation, not a judgment about risk. The Health Ministry’s 2026 protocol weighs how many people develop the disease in each age band against how many exams the health system can actually deliver, UOL reported.

“It is a balance between the use of public resources and lives saved. That equation is what matters most: you want to save the largest possible number of lives within the resources you have available,” said Samuel Aguiar Jr., líder do Centro de Referência de Tumores Colorretais do A.C.Camargo Cancer Center, in comments to UOL.
Some medical societies have already moved their own recommendation down. The American Cancer Society lowered its screening start age from 50 to 45 in 2018, citing rising diagnoses in younger adults, and the Brazilian Society of Coloproctology now recommends routine colonoscopy from 45. Aguiar told UOL that pushing the public program below 50 would multiply the number of people referred for exams, including many without symptoms.
“Screening from age 50 upward is already a challenge in a country like Brazil. We already have enormous waiting lists — sometimes even in the private sector — for colonoscopies,” Aguiar told UOL.
Danilo Munhóz, da Clínica Primazo e coloproctologista pela Sociedade Brasileira de Coloproctologia (SBCP), told UOL that guideline committees weigh how many people develop the disease, how many die, how many lives earlier testing would save, and the risks of the procedures themselves.
The disease is moving younger
The tension behind the age cutoff is a real epidemiological shift. Colorectal cancer cases in Brazil are growing more than 7% a year among people under 50, reaching an 8.5% annual increase in the 30-to-39 age group, oncologist Nildevande Firmino told Rádio Folha in an interview carried by Folha PE.
INCA registers thousands of new cases each year, making it the third most prevalent cancer in the country, according to Correio do Povo.
The United States shows the same pattern. Cases among Americans aged 45 to 49 grew 12.76% a year between 2019 and 2023 — the steepest rise of any age group studied — and American Cancer Society data show a roughly 3% annual increase among adults 20 to 49 between 2013 and 2022.
Firmino tied the trend to decades of behavioral and dietary change, telling Rádio Folha that someone born around 1990 carries roughly twice the colon cancer risk — and four times the rectal cancer risk — of a generation born in the mid-1950s.
Under the World Health Organization’s classification of carcinogenic foods, he noted, 50 grams of processed meat a day — two slices of ham or one sausage — raises colorectal cancer risk by about 18%, with red meat carrying added risk at 100 grams daily.
The public figures touched by the disease have sharpened attention: singer Preta Gil died of it in 2025 at 50, and actress Lua Blanco died this year at 39, Correio do Povo reported.
How the December test works
The FIT detects microscopic blood in stool, invisible to the naked eye, that can signal polyps, precancerous lesions or tumors. Meio News reported the test was chosen for being noninvasive, requiring no bowel preparation or dietary changes, with an estimated accuracy between 85% and 92%.
From December, teams at basic health units will identify and invite eligible patients for a consultation, then hand them a container for a stool sample collected at home or at the clinic, according to Estadão and Meio News.
A positive result triggers referral for a colonoscopy; a negative result means repeating the test in two years. Patients who may benefit from specialist evaluation can seek out colorectal cancer care pathways listed by INCA, and privately, board-certified coloproctologists and endoscopy diagnostic centers offer the same screening chain outside the public program.
The colonoscopy remains the definitive tool. Firmino told Rádio Folha it does more than diagnose — it removes precancerous polyps during the exam itself, and some of his patients were cured at the first procedure alone, with no surgery or chemotherapy. He put the cure rate above 90% when disease is caught early, against roughly 60% of Brazilian cases arriving already advanced.

For people with a family history of colon cancer, the Brazilian Society of Coloproctology’s guidance, as Firmino relayed it, is to start colonoscopy about 10 years before the age at which the relative was diagnosed.
Signs that should not wait for 50
Screening programs cover only the symptom-free. Doctors quoted across the coverage list the warning signs that demand immediate evaluation at any age: blood in the stool, persistent abdominal pain or discomfort, unexplained weight loss, and changes in bowel habit or in the frequency and consistency of stools. Unexplained anemia belongs on that list too, Ghezzi told Correio do Povo.
“The problem with the young patient is that he doesn’t go get a colonoscopy. He’ll have a little pain here and another there, generally won’t pay attention to his bowel habits, and will only do the exam when he’s very symptomatic,” Ghezzi told Correio do Povo.
That delay is the quiet cost of the age cutoff. University of Chicago researchers told ScienceDaily that people under 45 should not ignore possible symptoms simply because they have not reached the recommended screening age.
The gap the program leaves open
The December rollout narrows one gap — access — while leaving another: the 400,000 initial tests against 51 million eligible people, and an age floor that excludes the group where incidence is climbing fastest.
Medical societies including the Brazilian Society of Digestive Endoscopy, the Brazilian Federation of Gastroenterology and the Brazilian Society of Coloproctology lead the country’s prevention campaign, Correio do Povo reported, and they continue to recommend colonoscopy from 45 for those who can access it.
“When the diagnosis is early, the chances of cure exceed 90%. The best weapon against colorectal cancer, without a doubt, is prevention and early diagnosis,” Firmino told Rádio Folha.
The screening program lands in a system with a broad reach. The SUS was created by Federal Law Number 8.080 on 19 September 1990, consolidating the health provisions of the 1988 Constitution, which declared health “a right of all and an obligation of the State.” Before that, only people who contributed to social security could receive health care.
Today it is the largest government-run public health care system in the world, serving virtually the entire Brazilian population of 220 million people through more than 50,000 clinics, and it is free at the point of service for anyone, including foreigners.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.